Long-term antiviral treatment for recurrent hepatitis C after liver transplantation

Digestive and Liver Disease

Volumn 44, Issue 10, 2012, Pages 861-867

  Bertuzzo, Valentina Rosa ^a   Cescon, Matteo ^a   Morelli, Maria Cristina ^a   Di Gioia, Paolo ^a   Tamè, Mariarosa ^a   Lorenzini, Stefania ^a   Andreone, Pietro ^a   Ercolani, Giorgio ^a   Del Gaudio, Massimo ^a   Ravaioli, Matteo ^a   Cucchetti, Alessandro ^a   Dazzi, Alessandro ^a   D'Errico Grigioni, Antonietta ^a   Pinna, Antonio Daniele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antiviral treatment; HCV recurrence; Liver transplantation; Non responder

Indexed keywords

ALPHA2B INTERFERON; CYCLOSPORIN A; EVEROLIMUS; PEGINTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RAPAMYCIN; RIBAVIRIN; TACROLIMUS;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; DISEASE COURSE; DRUG DOSE INCREASE; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT INFECTION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VIROLOGICAL RESPONSE; VIRUS LOAD;

ADULT; AGED; ANTIVIRAL AGENTS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-ALPHA; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; RECURRENCE; RETROSPECTIVE STUDIES; RIBAVIRIN; RNA, VIRAL; SURVIVAL RATE;

EID: 84865760655     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.06.013     Document Type: Article

References (33)

1. Organ Procurement and Transplantation Network. Liver transplantation in the United States, 1999-2008. Available at: http://optn.transplant.hrsa.gov/ar2009/chapter_iv_AR_cd.htm%3Fcp=5.
2. Adam R., McMaster P., O'Grady J.G., et al. European Liver Transplant Association. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transplantation 2003, 9:1231-1243.
3. Wali M., Harrison R.F., Gow P.J., et al. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 2002, 51:248-252.
4. Mutimer D.J., Gunson B., Chen J., et al. Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation 2006, 81:7-14.
5. Rayhill S.C., Wu Y.M., Katz D.A., et al. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C. Transplantation 2007, 84:331-339.
6. Gane E. The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients. Liver Transplantation 2003, 9:S28-S34.
7. Forman L.M., Lewis J.D., Berlin J.A., et al. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002, 122:889-896.
8. Burra P., Hepatitis C. Seminars in Liver Disease 2009, 29:53-65.
9. Ercolani G., Grazi G.L., Ravaioli M., et al. Histological recurrent hepatitis C after liver transplantation: outcome and role of retransplantation. Liver Transplantation 2006, 12:1104-1111.
10. Rowe I.A., Barber K.M., Birch R., et al. Retransplantation for graft failure in chronic hepatitis C infection: a good use of a scarce resource?. World Journal of Gastroenterology 2010, 16:5070-5076.
11. Wiesner R.H., Sorrell M., Villamil F. International Liver Transplantation Society Expert Panel. Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C. Liver Transplantation 2003, 9:S1-S9.
12. Carrión J.A., Navasa M., García-Retortillo M., et al. Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study. Gastroenterology 2007, 132:1746-1756.
13. Samuel D., Bizollon T., Feray C., et al. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Gastroenterology 2003, 124:642-650.
14. Cescon M., Grazi G.L., Cucchetti A., et al. Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation. Liver Transplantation 2009, 15:782-789.
15. Sharma R., Ryan C., Safadjou S., et al. Response to antiviral therapy in liver transplant recipients with recurrent hepatitis C viral infection: a single center experience. Clinical Transplantation 2010, 24:104-111.
16. Hanouneh I.A., Miller C., Aucejo F., et al. Recurrent hepatitis C after liver transplantation: on-treatment prediction of response to peginterferon/ribavirin therapy. Liver Transplantation 2008, 14:53-58.
17. Giostra E., Kullak-Ublick G.A., Keller W., et al. Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation. Transplant International 2004, 17:169-176.
18. Heydtmann M., Freshwater D., Dudley T., et al. Pegylated interferon alpha-2b for patients with HCV recurrence and graft fibrosis following liver transplantation. American Journal of Transplantation 2006, 6:825-833.
19. Kornberg A., Hommann M., Tannapfel A., et al. Long-term combination of interferon alfa-2b and ribavirin for hepatitis C recurrence in liver transplant patients. American Journal of Transplantation 2001, 1:350-355.
20. Stravitz R.T., Shiffman M.L., Sanyal A.J., et al. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation. Liver Transplantation 2004, 10:850-858.
21. Walter T., Scoazec J.Y., Guillaud O., et al. Long-term antiviral therapy for recurrent hepatitis C after liver transplantation in nonresponders: biochemical, virological, and histological impact. Liver Transplantation 2009, 15:54-63.
22. Ikegami T., Taketomi A., Soejima Y., et al. The benefits of interferon treatment in patients without sustained viral response after living donor liver transplantation for hepatitis C. Transplantation Proceedings 2009, 41:4246-4252.
23. Kamath P.S., Wiesner R.H., Malinchoc M., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001, 33:464-470.
24. Simmonds P., Alberti A., Alter H.J., et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994, 19:1321-1324.
25. Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. Journal of Hepatology 1995, 22:696-699.
26. Lionetti R., Tisone G., Palmieri G., et al. Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression. Digestive and Liver Disease 2010, 42:297-303.
27. Tisone G., Orlando G., Cardillo A., et al. Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. Journal of Hepatology 2006, 44:702-709.
28. Ballarin R., Cucchetti A., Spaggiari M., et al. Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors: a European multicentric case-control study. Transplantation 2011, 91:1265-1272.
29. Saab S., Ghobrial R.M., Ibrahim A.B., et al. Hepatitis C positive grafts may be used in orthotopic liver transplantation: a matched analysis. American Journal of Transplantation 2003, 3:1167-1172.
30. Velidedeoglu E., Desai N.M., Campos L., et al. The outcome of liver grafts procured from hepatitis C-positive donors. Transplantation 2002, 73:582-587.
31. Bizollon T., Pradat P., Mabrut J.Y., et al. Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C. American Journal of Transplantation 2005, 5:1909-1913.
32. Berenguer M., Palau A., Fernandez A., et al. Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C. Liver Transplantation 2006, 12:1067-1076.
33. Neumann U.P., Berg T., Bahra M., et al. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. Journal of Hepatology 2004, 41:830-836.